ATE155477T1 - Gangliosideanaloge - Google Patents

Gangliosideanaloge

Info

Publication number
ATE155477T1
ATE155477T1 AT92923719T AT92923719T ATE155477T1 AT E155477 T1 ATE155477 T1 AT E155477T1 AT 92923719 T AT92923719 T AT 92923719T AT 92923719 T AT92923719 T AT 92923719T AT E155477 T1 ATE155477 T1 AT E155477T1
Authority
AT
Austria
Prior art keywords
group
bond
pct
together form
formula
Prior art date
Application number
AT92923719T
Other languages
English (en)
Inventor
Hans Goeran Magnusson
Kumar Ray Asim
Original Assignee
Symbicom Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DK911853A external-priority patent/DK185391D0/da
Priority claimed from DK88092A external-priority patent/DK88092D0/da
Application filed by Symbicom Ab filed Critical Symbicom Ab
Application granted granted Critical
Publication of ATE155477T1 publication Critical patent/ATE155477T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02Acyclic radicals, not substituted by cyclic structures
    • C07H15/04Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/646Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02Acyclic radicals, not substituted by cyclic structures
    • C07H15/12Acyclic radicals, not substituted by cyclic structures attached to a nitrogen atom of the saccharide radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT92923719T 1991-11-11 1992-11-11 Gangliosideanaloge ATE155477T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK911853A DK185391D0 (da) 1991-11-11 1991-11-11 Carbonhydratderivater
DK88092A DK88092D0 (da) 1992-07-03 1992-07-03 Carbonhydratderivater

Publications (1)

Publication Number Publication Date
ATE155477T1 true ATE155477T1 (de) 1997-08-15

Family

ID=26064834

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92923719T ATE155477T1 (de) 1991-11-11 1992-11-11 Gangliosideanaloge

Country Status (8)

Country Link
US (1) US5637569A (de)
EP (1) EP0642523B1 (de)
JP (1) JPH07504884A (de)
AT (1) ATE155477T1 (de)
AU (1) AU674293B2 (de)
CA (1) CA2123213A1 (de)
DE (1) DE69220970D1 (de)
WO (1) WO1993010134A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69530910D1 (de) * 1994-07-15 2003-07-03 Taiyo Kagaku Co Medizinische zusammensetzungen enthaltend ein sialinsäurederivat
ES2303337T3 (es) 1995-01-20 2008-08-01 G.D. Searle Llc Inhibidores de la proteasa retroviral de bis-hidroxietilamino sulfonamida.
US6355244B1 (en) 1997-11-17 2002-03-12 University Of Kentucky Research Foundation Methods and compositions for the treatment of psoriasis
WO1999052931A1 (fr) 1998-04-10 1999-10-21 Mitsubishi Chemical Corporation Dispersion solide contenant un derive d'acide sialique
US6761816B1 (en) * 1998-06-23 2004-07-13 Clinical Micro Systems, Inc. Printed circuit boards with monolayers and capture ligands
US6245902B1 (en) * 1999-08-09 2001-06-12 University Of Iowa Research Foundation C-glycoside analogs and methods for their preparation and use
EP1409712A4 (de) * 2001-04-10 2008-05-14 Bioprocessors Corp Mikrofermentervorrichtung und screeningverfahren auf zellbasis
US20040058407A1 (en) * 2001-04-10 2004-03-25 Miller Scott E. Reactor systems having a light-interacting component
EP2411526A4 (de) * 2009-03-27 2012-09-19 Zacharon Pharmaceuticals Inc Modulatoren der gangliosidenbiosynthese
AR093275A1 (es) * 2010-03-17 2015-05-27 Centro De Excelencia En Productos Y Procesos De Cordoba (Ceprocor) Una composicion farmaceutica soluble en agua que comprende al menos una sustancia terapeuticamente activa de caracteristicas hidrofobicas y al menos un compuesto seleccionado entre los sialoglicoesfingolipidos, los glicoesfingolipidos o una mezcla de sialoglicoesfingolipidos y glicoesfingolipidos
WO2013138563A1 (en) * 2012-03-16 2013-09-19 University Of Geogia Research Foundation, Inc. Glycomimetics to inhibit pathogen-host interactions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1199116B (it) * 1984-07-03 1988-12-30 Fidia Farmaceutici Derivati di gangliosidi
IT1212041B (it) * 1987-11-02 1989-11-08 Fidia Farmaceutici Gangliosidi esteri interni come agenti terapeutici capaci di eliminare il dolore nelle neuropatie periferiche
US5079353A (en) * 1987-12-02 1992-01-07 Chembiomed, Ltd. Sialic acid glycosides, antigens, immunoadsorbents, and methods for their preparation

Also Published As

Publication number Publication date
WO1993010134A1 (en) 1993-05-27
EP0642523B1 (de) 1997-07-16
DE69220970D1 (en) 1997-08-21
EP0642523A1 (de) 1995-03-15
JPH07504884A (ja) 1995-06-01
US5637569A (en) 1997-06-10
AU674293B2 (en) 1996-12-19
CA2123213A1 (en) 1993-05-27
AU2942892A (en) 1993-06-15

Similar Documents

Publication Publication Date Title
ATE155477T1 (de) Gangliosideanaloge
DK0405864T3 (da) Phospholipase A2-inhibitor, mikroorganismer der producerer inhibitoren og fremgangsmåder til den fremstilling
ES2071621T3 (es) Enantiomero dextrogiro del alfa-(tetrahidro-4,5,6,7-tieno-(3,2-c)-piridil-5)(cloro-2-fenil) acetato de metilo, su procedimiento de preparacion y las composiciones farmaceuticas que lo contienen.
IL111843A (en) Crystalline 3,4,4-trisubstituted piperidinyl-N-(3-phenylprop-2-YL) carboxylic acid derivatives pharmaceutical compositions containing them and processes for their preparation
EA199800290A1 (ru) (метилсульфонил) фенил-2-(5н)-фураноны в качестве ингибиторов циклооксигеназы-2
DE69615444D1 (de) Hyperverzweigte Polyaspartatester und Verfahren zu ihrer Herstellung
DE3584158D1 (de) Prostaglandinanaloge, verfahren zu ihrer herstellung und ihre pharmazeutischen zusammenstellungen.
ATE51617T1 (de) Verfahren zur herstellung von 4-phenyl-pyrrolderivaten.
AR246521A1 (es) Un procedimiento para la preparacion de derivados del cromeno.
ATE212349T1 (de) Neues verfahren zur herstellung von nucleosiden
MY118074A (en) Soap bar composition.
ES2128554T3 (es) Nuevos derivados del acido glutamico, procedimiento para su preparacion y su utilizacion como medicamentos para el aumento de la memoria y aprendizaje.
HUT56557A (en) Process for producing oxetanone derivatives and pharmaceutical compositions comprising same as active ingredient
ATE42545T1 (de) Imidazolide, verfahren zu deren herstellung und deren anwendung als zwischenprodukte in der synthese von cytotoxischen nebenprodukten.
ATE93509T1 (de) Monoester von dicarbonsaeuren, ihre herstellung und verwendung.
NO975371L (no) Farmasöytisk sammensetning fremstilt ved tilföring av en smakstilsetningsbærer til et medikament
DK0738258T3 (da) Fremgangsmåde til fremstilling af N-substituerede glycinsyrer eller glycinestere og anvendelse af fremgangsmåden til indigo
GB1514389A (en) Glycerides with antibacterial properties
IE872578L (en) Antigestagen compositions
EP0281826A3 (de) Verfahren zur Herstellung von (R)-4-Amino-3-hydroxybutansäure (GABOB)
MX9804752A (es) Conjugados covalentes de lipidos-acidos fosfonocarboxilicos, la produccion de los mismos asi como su uso como agentes farmaceuticos antivirales .
EG18643A (en) Pharmaceutical compositions containing trapidil,a process for the preparation thereof and related therapeutic use
ES2001564A6 (es) Procedimiento para la obtencion de tiazolilalquil y tienilalquilesteres de los acidos alfa-imidazolinon nicotinicos y benzoicos
GR1000469B (el) Mεθοδος παρασκευης κινολινοκαρβοξυλικων οξεων.
NZ332245A (en) Substituted benzo-oxazolol carboxylic acid derivatives, process for their production and medicaments containing them